James Francese Biography and Net Worth



Mr. Francese has 22 years of experience in ophthalmology, including 14 years marketing surgical products with Abbott Medical Optics (AMO), formerly Advanced Medical Optics and Allergan. During his time at AMO from 1990 to 2012, Mr. Francese held several positions of executive level responsibilities, including Head of Marketing, Americas for all surgical, refractive and corneal products, Head of Global Corneal Marketing responsible for all consumer products, and V.P. of Asia Pacific Region where he had full financial responsibility for cataract and refractive product lines during his tenure. He received his B.S. from Cornell University, M.S. from the University of Washington and M.B.A. from the University of Southern California.

What is James E. Francese's net worth?

The estimated net worth of James E. Francese is at least $871,652.76 as of September 27th, 2022. Mr. Francese owns 34,908 shares of STAAR Surgical stock worth more than $871,653 as of December 26th. This net worth estimate does not reflect any other investments that Mr. Francese may own. Additionally, Mr. Francese receives an annual salary of $755,650.00 as VP at STAAR Surgical. Learn More about James E. Francese's net worth.

How old is James E. Francese?

Mr. Francese is currently 60 years old. There are 6 older executives and no younger executives at STAAR Surgical. The oldest executive at STAAR Surgical is Mr. Thomas G. Frinzi, President, CEO & Chairman, who is 68 years old. Learn More on James E. Francese's age.

What is James E. Francese's salary?

As the VP of STAAR Surgical, Mr. Francese earns $755,650.00 per year. The highest earning executive at STAAR Surgical is Mr. Thomas G. Frinzi, President, CEO & Chairman, who commands a salary of $1,220,000.00 per year. Learn More on James E. Francese's salary.

How do I contact James E. Francese?

The corporate mailing address for Mr. Francese and other STAAR Surgical executives is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. STAAR Surgical can also be reached via phone at (626) 303-7902 and via email at [email protected]. Learn More on James E. Francese's contact information.

Has James E. Francese been buying or selling shares of STAAR Surgical?

James E. Francese has not been actively trading shares of STAAR Surgical during the past quarter. Most recently, James E. Francese sold 35,425 shares of the business's stock in a transaction on Tuesday, September 27th. The shares were sold at an average price of $75.00, for a transaction totalling $2,656,875.00. Following the completion of the sale, the vice president now directly owns 34,908 shares of the company's stock, valued at $2,618,100. Learn More on James E. Francese's trading history.

Who are STAAR Surgical's active insiders?

Are insiders buying or selling shares of STAAR Surgical?

During the last twelve months, STAAR Surgical insiders bought shares 8 times. They purchased a total of 246,915 shares worth more than $6,736,641.74. The most recent insider tranaction occured on December, 18th when Major Shareholder Broadwood Partners, L.P. bought 23,000 shares worth more than $559,590.00. Insiders at STAAR Surgical own 1.0% of the company. Learn More about insider trades at STAAR Surgical.

Information on this page was last updated on 12/18/2024.

James E. Francese Insider Trading History at STAAR Surgical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/27/2022Sell35,425$75.00$2,656,875.0034,908View SEC Filing Icon  
3/21/2022Sell922$74.62$68,799.64View SEC Filing Icon  
3/14/2022Sell289$64.18$18,548.02View SEC Filing Icon  
8/18/2021Sell15,000$146.91$2,203,650.0057,630View SEC Filing Icon  
5/10/2021Sell11,583$125.72$1,456,214.7654,788View SEC Filing Icon  
See Full Table

James E. Francese Buying and Selling Activity at STAAR Surgical

This chart shows James E Francese's buying and selling at STAAR Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

STAAR Surgical Company Overview

STAAR Surgical logo
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Read More

Today's Range

Now: $24.49
Low: $24.22
High: $24.76

50 Day Range

MA: $27.71
Low: $23.93
High: $31.46

2 Week Range

Now: $24.49
Low: $23.72
High: $52.68

Volume

163,940 shs

Average Volume

700,167 shs

Market Capitalization

$1.21 billion

P/E Ratio

55.66

Dividend Yield

N/A

Beta

0.59